Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 02 Jun 2025

The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study

in Cancer Immunity and Immunotherapy

Baoyue Pan
He Huang
Ting Wan
Qidan Huang
Shanyang He
Shijie Xu
Siyu Chen
Jiaxin Yin
Jundong Li
Min Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1582299

Original Research

Published on 02 Jun 2025

Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging

in Cancer Immunity and Immunotherapy

Weihao Zhang
Xiaohui Zhao
Wei Gao
Tongguo Si
Qiang Zou
Xueling Yang
Wenge Xing
Haipeng Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1596864

Mini Review

Published on 02 Jun 2025

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations

in Cancer Immunity and Immunotherapy

Xinyu Li
Hui Qiu
Qiuji Wu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601572

Original Research

Accepted on 30 May 2025

Cross-Cohort Multi-Omics Analysis Identifies Novel Clusters Driven by EMT Signatures in Colorectal Cancer

in Cancer Immunity and Immunotherapy

Wu Ning
Wenqing Jia
Jingyuan Ning
Lei Zhou
Zongze Li
Lin Zhang
Xin Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1628005

155 views

Mini Review

Accepted on 30 May 2025

The Novel Functions of Chemokines in Lung Cancer Progression

in Cancer Immunity and Immunotherapy

Xiaorui Gong
Xueying Wang
Jing Jin
ZhiQiang Gong

Frontiers in Immunology

doi 10.3389/fimmu.2025.1607225

145 views

Original Research

Accepted on 30 May 2025

A Retrospective Efficacy and Safety Study of Pembrolizumab/ Cetuximab Neoadjuvant Therapy in Locally Advanced Hypopharyngeal Cancer

in Cancer Immunity and Immunotherapy

Guangnan Yao
Xiaobo Wu
Hanqing Lin
Zhihong Chen
Chang Lin
Gongbiao Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1574988

Original Research

Accepted on 30 May 2025

Exploring the predictive "psycho-biomarkers" for Checkpoint Immunotherapy in cancer

in Cancer Immunity and Immunotherapy

Qian Zuo
Jieting Chen
Xi Xiao
Yan Dai
Liushan Chen
Yuqi Liang
Yingchao Wu
Rutao Cui
XU RUI
Qianjun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590670

111 views

Correction

Accepted on 30 May 2025

Correction: Development and validation of an ARID1A-related immune genes risk model in evaluating prognosis and immune therapeutic efficacy for gastric cancer patients: a translational study

in Cancer Immunity and Immunotherapy

Jiangtao Zhang
Jingting Li
Shangfeng Yang
Xiaoyan Tang
Chunze Wang
Jiaxing Lin
Qiancheng Chen
Hui Xu
Yuanyuan Ma
Xiaoling Gao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1637370

Original Research

Accepted on 30 May 2025

Systematic pan-cancer analysis identifies PKNOX1 as a potential prognostic and immunological biomarker and its functional validation

in Cancer Immunity and Immunotherapy

KAN LIU
Yongkang Xu
Ye Mao
Shumin Fu
Jianbing Wu
Shenglan Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1533690

Systematic Review

Accepted on 30 May 2025

BioBERT-Powered Synergy: Advanced Bibliometric and Molecular Insights into Prostate Cancer Bone Metastasis

in Cancer Immunity and Immunotherapy

Zile Liu
Zexin Chen
Kangyi Xue
Ming Kun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562559

Review

Accepted on 30 May 2025

Lactylation in tumor: mechanisms and therapeutic potentials

in Cancer Immunity and Immunotherapy

Dandan Wang
Hao Rong
Ke Ma
Jun Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1609596

Original Research

Accepted on 30 May 2025

Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective

in Cancer Immunity and Immunotherapy

Zheng Lu
Deng-Yong Zhang
Yan Zhu
Zhonglin Wang
Xinrui Li
Jingyuan Fan
Yuhang Yang
Sophia Han
Wanliang Sun
Dongdong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1614683

201 views

Original Research

Published on 30 May 2025

Immunogenomic characteristics and prognostic implications of terminally exhausted CD8+ T cells in colorectal cancers

in Cancer Immunity and Immunotherapy

Ji-Ae Lee
Hye Eun Park
Dae-Won Lee
Sae-Won Han
Tae-You Kim
Seung-Yong Jeong
Kyu Joo Park
Jeong Mo Bae
Gyeong Hoon Kang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601188

218 views

Review

Published on 30 May 2025

CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy

in Cancer Immunity and Immunotherapy

Filipa D. dos Reis
Yanis Saidani
Paula Martín-Rubio
Rebeca Sanz-Pamplona
Ana Stojanovic
Margareta P. Correia

Frontiers in Immunology

doi 10.3389/fimmu.2025.1603757

756 views

Original Research

Published on 30 May 2025

Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer

in Cancer Immunity and Immunotherapy

Ziyang Zeng
Jian Zhou
Weili Zhang
Jianhong Peng
Yuan Li
E-er-man-bie-ke Jin-si-han
Hao Wang
Shaopu Lian
Cheng Feng
Chuanmiao Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1589869

308 views

Case Report

Published on 30 May 2025

Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient

in Cancer Immunity and Immunotherapy

Wenrui Wang
Wei Li
Tianqi Zhang
Zhenjing Jin
Lanlan Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565065

165 views